Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients

Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells... original article Wien Klin Wochenschr (2017) 129:545–551 DOI 10.1007/s00508-017-1205-z Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients Barbara Skopec · Matevz Skerget · Darja Zontar · Vesna Zadnik · Samo Zver Received: 17 August 2016 / Accepted: 31 March 2017 / Published online: 24 April 2017 © Springer-Verlag Wien 2017 Summary median time to neutrophil and platelet engraftment Background Autologous hematopoietic stem cell was 13 days and 16.5 days for filgrastim and 13 days transplantation (aHSCT) is the recommended stan- and 16 days for pegfilgrastim group. dard upfront treatment for transplant eligible myeloma Conclusions We can conclude that pegfilgrastim alone patients. Considering possible complications related is at least equally successful as filgrastim alone for to chemotherapy–cytokine mobilization, cytokine- the PBSC mobilization in newly diagnosed myeloma alone mobilization is often used. We compared mo- patients. bilization with filgrastim alone to pegfilgrastim alone in newly diagnosed myeloma patients after induction Keywords Multiple myeloma · Autologous stem cell treatment with bortezomib and dexamethasone. The transplantation · Mobilization · Pegfilgrastim · Filgras- comparison was made between peripheral blood stem tim cell (PBSC) yields, number of apheresis, hematopoi- etic stem cell subsets, and time to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Wiener klinische Wochenschrift Springer Journals

Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients

Loading next page...
 
/lp/springer_journal/filgrastim-alone-versus-pegylated-filgrastim-alone-for-autologous-LSIALxsEIs
Publisher
Springer Vienna
Copyright
Copyright © 2017 by Springer-Verlag Wien
Subject
Medicine & Public Health; Medicine/Public Health, general; Internal Medicine; Endocrinology; Gastroenterology; Pneumology/Respiratory System
ISSN
0043-5325
eISSN
1613-7671
D.O.I.
10.1007/s00508-017-1205-z
Publisher site
See Article on Publisher Site

Abstract

original article Wien Klin Wochenschr (2017) 129:545–551 DOI 10.1007/s00508-017-1205-z Filgrastim-alone versus pegylated filgrastim-alone for autologous peripheral blood stem cells mobilization in newly diagnosed multiple myeloma patients Barbara Skopec · Matevz Skerget · Darja Zontar · Vesna Zadnik · Samo Zver Received: 17 August 2016 / Accepted: 31 March 2017 / Published online: 24 April 2017 © Springer-Verlag Wien 2017 Summary median time to neutrophil and platelet engraftment Background Autologous hematopoietic stem cell was 13 days and 16.5 days for filgrastim and 13 days transplantation (aHSCT) is the recommended stan- and 16 days for pegfilgrastim group. dard upfront treatment for transplant eligible myeloma Conclusions We can conclude that pegfilgrastim alone patients. Considering possible complications related is at least equally successful as filgrastim alone for to chemotherapy–cytokine mobilization, cytokine- the PBSC mobilization in newly diagnosed myeloma alone mobilization is often used. We compared mo- patients. bilization with filgrastim alone to pegfilgrastim alone in newly diagnosed myeloma patients after induction Keywords Multiple myeloma · Autologous stem cell treatment with bortezomib and dexamethasone. The transplantation · Mobilization · Pegfilgrastim · Filgras- comparison was made between peripheral blood stem tim cell (PBSC) yields, number of apheresis, hematopoi- etic stem cell subsets, and time to

Journal

Wiener klinische WochenschriftSpringer Journals

Published: Apr 24, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off